Skip to main content
. 2021 Apr 23;47(5):1331–1341. doi: 10.1093/schbul/sbab043

Table 1.

Descriptive Information on all Measures

Year 20 Completers (n = 316) Year 20 Non-completers (n = 153) P-value for Mean Comparisons
Mean (SD) or % Mean (SD) or %
Demographics
 Women 39% 45% .20
 Age at 6-mo wave (y) 28.80 (8.99) 31.95 (9.99) <.05
 White 83% 70% .02
Diagnostic measures at 6 mo
 HiTOP dimensions
  SAPS Reality Distortion 2.77 (5.76) 3.44 (6.91) .26
  SAPS Disorganization 2.13 (4.01) 2.16 (3.41) .95
  SANS Avolition 8.74 (7.68) 10.06 (7.69) .08
  SANS Inexpressivity 6.78 (8.11) 6.90 (8.21) .88
  QLS Global Functioning 2.70 (1.21) 2.47 (1.17) .06
 DSM-IV Diagnoses
  Schizophrenia 35% 36% .91
  Bipolar disorder with psychotic features 28% 25% .53
  Major depressive disorder with psychotic features 18% 20% .71
  Substance-induced psychosis 7% 9% .32
  Other psychoses 12% 10% .56
Outcomes at 20 years Mean (SD) or %
 Psychiatric outcomes
  Recovery 46%
  Full Symptom Remission 29%
 Community functioning
  Educational attainment (any college) 40%
  Employed 55%
  Public assistance 63%
  Role functioning 2.55 (1.14)
  Living independently over the interval 0.95 (0.68)
  Social functioning 10.25 (4.49)
  WHO-DAS Global Disability 22.06 (8.70)
 Physical health
  Diabetes 21%
  Hypertension 30%
 Neural responses
  MMN duration (μV) −1.60 (1.85)
  MMN frequency (μV) −1.75 (1.43)
  P3a amplitude (μV) 8.54 (5.15)
  P3a latency (ms) 390.49 (61.33)
 Cognitive functioning
  Composite score −11.55 (73.78)

Note: SAPS, Scale for the Assessment of Positive Symptoms; SANS, Scale for the Assessment of Negative Symptoms; QLS, Quality of Life Scale; WHO-DAS, World Health Organization Disability Assessment Schedule; MMN, mismatched negativity.